Currently AChE inhibitors such as donepezil, rivastigmine, and galantamine are commonly used to increase the level and duration of acetylcholine and facilitate cholinergic transmission in AD (Marucci et al., 2021). The gene discussed is ACHE; the disease is Alzheimer disease.